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Red Ear Syndrome (RES) is a very rare disorder, with approximately 100 published cases in the medical literature.
Red ear (RE) episodes are characterised by unilateral or bilateral attacks of paroxysmal burning sensations and
reddening of the external ear. The duration of these episodes ranges from a few seconds to several hours. The
attacks occur with a frequency ranging from several a day to a few per year. Episodes can occur spontaneously or
be triggered, most frequently by rubbing or touching the ear, heat or cold, chewing, brushing of the hair, neck
movements or exertion. Early-onset idiopathic RES seems to be associated with migraine, whereas late-onset
idiopathic forms have been reported in association with trigeminal autonomic cephalalgias (TACs). Secondary forms
of RES occur with upper cervical spine disorders or temporo-mandibular joint dysfunction. RES is regarded
refractory to medical treatments, although some migraine preventative treatments have shown moderate benefit
mainly in patients with migraine-related attacks. The pathophysiology of RES is still unclear but several hypotheses
involving peripheral or central nervous system mechanisms have been proposed.
Keywords: Red ear syndrome; Migraine; Trigemino-autonomic reflex; Trigeminal autonomic cephalalgias;
Parasympathetic system; ErythromelalgiaReview
Introduction
Red Ear Syndrome (RES) is a rare condition originally
described by Lance in 1994 [1] and further characterized
in 1996 [2]. Since the initial description, approximately
100 cases have been described in the literature [3-21].
The syndrome itself has not been clearly defined. Apart
from its unique clinical presentation, characterised by
episodes of burning pain and reddening of the external
ear, the condition lacks definition in terms of aetiology,
pathophysiology and treatments. It is for these reasons
that it has yet to be included in the revised International
Classification of Headache Disorders (ICHD-IIIβ) [22].
This article reviews the case descriptions, pathophysio-
logical theories and effective treatments reported in the
literature since the description of the first case in 1994.Epidemiology
The prevalence and incidence of RES is unknown, al-
though the low number of reported cases would suggest
that it is rare. There are 100 relatively complete case de-
scriptions of RES found in the English language literature.* Correspondence: m.matharu@uclmail.net
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in any medium, provided the original work is pThe disorder has a slight female preponderance (54
women, 47 men), with a male to female ratio of 1:1.25.
Interestingly, though, in the two series of young mi-
graineurs with RES described by Raieli et al. [5,13], the
majority of patients were males (75% and 68% of patients
respectively). From the available data (ages of onset not
provided by Raieli et al. [13]), the median age of onset of
RES is 44 years old, although a wide range of 4 to 92 years
is reported.Clinical features
Site of pain
Pain is felt over the pinna of the ear, often maximal on the
ear lobe. It can radiate towards the cheek and mandible
[16,20], as well as towards the occiput [4] and the involve-
ment of the V1 area or whole hemicranium has also been
described [1,10,12].Laterality of attack
From the original description, RE episodes were thought
to be predominantly unilateral and side-locked [1]. Subse-
quently, cases of unilateral attacks occurring on either side
in the same patient [16] as well as bilateral attacks have
been described [5,11,17]. In total, 62 patients (62%) had
strictly unilateral attacks, 31 (31%) bilateral attacks and 6an open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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for one patient.
Among patients with unilateral RE episodes, the pain is
reported more frequently on the left (58%) than the right
side (42%) (left-sided attacks: 30 patients; right-sided at-
tacks: 22 patients; data not available for 10 patients).Severity of pain
The degree of intensity of the pain episodes in RES has
not been properly assessed. Generally, it is reported as an
annoying discomfort rather than an excruciating pain.
However, authors do also report cases of patients com-
plaining of moderate to severe attacks. Lambru et al. de-
scribed a case of a patient with SUNA (Short-lasting
unilateral neuralgiform headache attacks with autonomic
symptoms) and RES occurring on the same side. The se-
verity of the RE episodes were felt by the patient to be
moderate (VRS: 5/10) compared to the excruciating inten-
sity of the SUNA attacks (VRS: 8-10/10), suggesting a
lower degree of severity of the pain of an RE episode com-
pared to that typical of a TAC attack [23]. However, some
authors have reported cases of patients complaining of se-
vere pain. Boes et al. described a patient with episodes of
left ear pain attacks associated with reddening that the pa-
tient described as severe. The attacks were suppressed
completely with indometacin 75 mg/day, supporting a
diagnosis of paroxysmal hemicrania-associated RES [3].Character of pain
Patients consistently described the pain as a burning sen-
sation. Other characters that have been less often reported
include a dull ache [1,4], a stabbing pain [2,3], a sharp pain
[2,10] and a jabbing pain [2].Duration of the individual attacks
The duration of each RE episode can vary widely. Gener-
ally, the attacks are short-lasting with 63 RES patients
(63%) reporting attacks lasting up to four hours. The
majority had attacks lasting 30 to 60 minutes [2,5,16].
However, short-lived attacks lasting seconds have been
reported [7]. Only six patients (6%) had attacks lasting
over 4 hours of whom two complained of constant pain
[2]. Data on duration of attacks in 32 patients was not
available from the case reported.Attack frequency and remission periods
The attack frequency varies immensely both among suf-
ferers and within individual sufferers. The majority of RES
patients report daily attacks ranging from one daily to up
to 20 attacks a day [9]. A small minority of patients only
report infrequent attacks that occur 1 to 6 times per
month [5].RE episodes occur most commonly during the daytime,
although Lance reported a case in whom RE attacks had
awakened the patient from sleep [2].
In most patients, RES seems to be a chronic problem
without significant remission periods, although, in some
cases the follow-up was too short to allow any meaningful
conclusion to be drawn [7,15]. Some case reports clearly
describe patients with episodic bouts of RES attacks al-
ternating with remission periods. Donnet and Valade de-
scribed a 92-year-old woman who experienced attacks of
burning pain and red ear associated with lacrimation fol-
lowing an episodic pattern. The episodes were short-
lasting, occurring in bouts of daily attacks lasting 15 to
45 days every 12–18 months [6]. Similarly, the case of a
36-year-old woman who complained of episodes of ear,
temple, cheek and upper neck pain associated with ear
redness and other autonomic symptoms such as conjunc-
tival injection, tearing and nasal blockage lasting between
10–60 minutes was described. She had daily attacks occur-
ring in “clusters”, presumably alternating with remission
periods [16]. Finally Boulton et al. described the case of a
66 year-old woman with a five year history of episodes of
pain behind the left ear and ear redness, initially occurring
in bouts of daily attacks lasting 1–2 weeks, followed by re-
missions lasing months but that subsequently became al-
most daily [10].
Associated features
The key clinical feature of RES is the presence of burning
ear pain associated with marked ear reddening although
Hirsch reported five patients with episodes of bright red
discoloration of the ears not associated with auricular pain
[18]. The erythema of the ear consistently follows the ear
pain and usually lasts as long as the burning pain does.
Rare exceptions to this pattern exist. Selekler et al. de-
scribed the case of a patient in whom the discoloration of
the ear would disappear within 10 min from the onset of
the attack, whereas the burning pain would continue for a
further 5–10 minutes [11] and Boulton et al. reported a
case of a 66 year-old woman in whom episodes of pain be-
hind the left ear were accompanied by reddening of the ip-
silateral ear only 50% of the time [10].
The area of reddening is usually limited to the external
ear and is most pronounced over the earlobe [2,5]. Simi-
larly to the pain pattern, the redness can extend beyond
the ear, most frequently involving the cheek [2,16]. In-
volvements of the temple, upper neck and rarely the entire
face ipsilaterally to the affected ear have also been
reported [2,12,16]. Given the complex sensory and auto-
nomic innervation of the external ear, it would be import-
ant to obtain more precise information on the area of
reddening to help clarify the pathophysiological mecha-
nisms at play. Unfortunately, besides some descriptions of
redness involving only the earlobe and one case in whom
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detail has been provided in the literature.
In the vast majority of RES patients, redness and
warmth of the ear are the only associated symptoms.
However, swelling of the ear during attacks has been
reported in three cases [2,17,19] and other cranial auto-
nomic symptoms such as aural fullness [3,9], ipsilateral
lacrimation [21] and ipsilateral conjunctival injection,
lacrimation and nasal blockage have also featured in the
literature [2,3,6,16]. Nausea, vomiting, photophobia, pho-
nophobia, osmophobia, motion sensitivity or restlessness
are not features of RES.
Triggers
Most patients with RES have both spontaneous and trig-
gered attacks. However, some patients can exhibit exclu-
sively spontaneous attacks (25 patients) [5,9,14] or triggered
attacks (14 patients) [2,7,11]. Triggers most often include:
heat (reported in six patients) [2,10,15,19,20], rubbing the
ear (three patients) [7,15,23], physical exercise (three pa-
tients) [2,9,20] and neck movement (three patients) [2,7].
Other cutaneous stimulations able to provoke RE episodes
include: light touching of the ear, brushing of the hair,
chewing, tooth grinding and showering [2,10,16]. Figure 1
shows a RE attack triggered by gentle rubbing of the ear
and Figure 2 a spontaneous attack in a different patient.
Anatomy, physiology and pathophysiology
Any attempt to define the pathophysiology of RES, must
explain the burning ear pain along with ear flushing as
well as the triggers of tactile stimuli and warmth. For this,Figure 1 A red ear syndrome attack, provoked by rubbing her right ean appreciation of the neural and vascular supply of the
ear is essential.
The earlobe and the lower external aspect of the ear are
innervated by the greater auricular nerve, a superficial
branch of the C2-C3 spinal nerves, whereas the tragus
and the anterosuperior aspect of the ear are supplied by
the auriculotemporal branch of the mandibular division of
the trigeminal nerve. The vascular supply of the ear is pro-
vided by branches of the middle temporal and posterior
auricular arteries, which, as part of the external carotid
circulation has sensory innervation of the blood supply
from the trigeminal nerve. The dominant mechanism of
vasomotor control of the skin of the ear is from variations
in sympathetic vasoconstrictor tone, whereas the facial
parasympathetic system seems to be only a marginal com-
ponent accounting mainly for forehead and cheek skin
vasodilation [24]. Importantly, vasodilation of the skin of
the ear seems to be provoked by an inhibition of the sym-
pathetic vasoconstrictor fibres as opposed to activation of
the facial parasympathetic fibres.
The pathophysiological mechanisms underlying RES are
currently unclear. However, several theories have been
proposed and can be divided into two main groups
namely, peripheral theories with mechanisms involving a
dysfunction in cervical spinal nerves (predominantly C3
root) and central theories in which the underlying mecha-
nisms would involve a dysregulation of brainstem trige-
mino-autonomic circuits.
In his original paper, Lance observed that RES was com-
monly associated with irritative lesions of the third cer-
vical nerve root and this led him to suggest that, in casesar.
Figure 2 A spontaneous red ear syndrome attack, in a patient with migraine.
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of impulses along C3 may occur leading to pain and vaso-
dilatation due to release of vasodilator peptides [2]. Sup-
port for this hypothesis appeared to come from the fact
that symptoms were temporarily relieved in one patient
following local anaesthetic block of the C3 root and per-
manently relieved in another patient after C3 section.
Lance also presented two cases in which attacks were trig-
gered but where the underlying cause was thought to be
TMJ dysfunction. In these cases he proposed that a local
axon reflex, triggered by non-noxious stimuli such as heat,
touch or chewing, might precipitate the antidromic dis-
charge. He postulated that RES might be an example of
Angry Back-firing C-nociceptors syndrome, in which the
phenomenon of ‘cross-modality threshold stimulation’ oc-
curs, whereby temperature changes alter the threshold for
the pain induced by mechanical stimulation [25]. It was
this hypothesis of an antidromic discharge from fibres of
the third cervical root causing vasodilation in the referred
pain area by discharge of vasodilator peptides, which led
Lance to label RES an auriculo-autonomic cephalgia,
though the exact mechanism by which C-fibres become
“angry” was not specified [26].
On the basis of the presence of RES features in a pa-
tient with paroxysmal hemicrania, Goadsby and Lipton
suggested that both conditions may share common
pathogenic mechanisms centred on the brainstem con-
nections between the trigeminal nerve and the facial
parasympathetic outflow. They suggested a primary role
for the dysregulation of brainstem trigemino-autonomic
circuits in the pathophysiology of the syndrome [27].The anatomical basis of this unifying hypothesis would
be the convergence of processing nociceptive information
at the level of the trigeminal nucleus caudalis and dorsal
horn nuclei of the upper cervical spine, of both trigeminal
afferents and C1-C2 spinal afferents. RES has subse-
quently been described in association with CH [16] and
SUNA [23], thereby supporting the possible nosological
and pathophysiological link between RES and TACs.
Given the frequent association of RES with migraine,
Raieli et al. proposed that symptoms of migraine-
associated RES may be due to the trigeminovascular acti-
vation during migraine attacks producing extracerebral
vasodilatation via direct release of vasodilator substances
(substance P, CGRP and nitric oxide) [5]. The activation of
the trigeminovascular system would explain the ear pain
that extends beyond the trigeminal distribution to the ear-
lobe, due to the overlap between trigeminal and upper
cervical spinal nerves in the trigemino-cervical complex
[28]. The same authors showed that RES was associated
with migraine features partially provoked by parasym-
pathetic system activation and concluded that RES could
be considered a specific sign of parasympathetic hyper-
activation, via the trigemino-autonomic reflex, during mi-
graine, in essence considering RES as a migraine-related
phenomenon, sharing activation of pathophysiological me-
chanisms known to be pivotal in migraine.
However, all these theories concerning a trigemino-
autonomic dysregulation as the main mechanism in RES
and RES associated with migraine and TACs raise an inter-
esting anatomical inconsistency. The trigemino-autonomic
reflex is based on a brainstem connection between the
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[27]. According to this hypothesis, the facial nerve para-
sympathetic outflow fibres that appear to be responsible
for the facial autonomic symptomatology in TACs should
also be able to produce vasodilation and therefore redness
of the skin of the ear in RES. However, unlike other parts
of the face, such as the cheek and the nose, the vasodila-
tion of the skin of the ear is mainly under sympathetic
vasoconstrictor control and occurs when there is inhib-
ition of the sympathetic vasoconstrictor fibres [24]. During
TACs attacks there is marked trigemino-parasympathetic
activation, along with a sympathetic deficit. It may be pos-
sible that in cases of RES in conjunction with TACs, the
presence of an imbalance between parasympathetic and
sympathetic systems in the latter may in turn facilitate the
inhibition of the sympathetic tone of the ear giving raise
to the red ear phenomenon. However, as it is the sympa-
thetic dysregulation and not a parasympathetic activation
that is the predominant mechanism for the ear reddening,
it seems less likely that the trigemino-autonomic reflex
plays a central role at least in isolated cases of RES. In-
deed, other mechanisms may contribute more specifically
to the red ear phenomenon.
A further pathophysiological hypothesis is based on the
fact that the clinical presentation of RES is strikingly simi-
lar to the clinical presentation of erythromelalgia (EM), a
dermatological condition characterised by paroxysmal epi-
sodes of burning pain and erythema often involving hands
and feet. The diagnostic criteria of EM include: burning
pain, aggravated by warmth and relieved by coldness, ery-
thema and increased skin temperature [29]. The patho-
physiology of EM is unfortunately unclear but local
primary damage of vascular and neuronal structures has
been proposed as the main pathophysiological mechanism
underlying it. In essence, it is postulated that primary vas-
cular misdistribution leading to skin hypoxia may cause a
secondary hypoxic-induced neuropathy. Conversely, pri-
mary small-fibre dysfunction may lead to a secondary
vascular misdistribution and hypoxia accompanied by sec-
ondary capillary proliferation [30,31]. Given the clinical
similarities, some authors have raised the possibility that
RES may be an auricular variant of EM, possibly caused
by similar small sensory and sympathetic nerve dysfunc-
tion [19]. Moreover, they stated that since a gene has been
identified in hereditary EM caused by mutations of Na 1.7
channels in sensory and sympathetic nerves [32], sodium-
channel blocking drugs may be a reasonable therapeutic
option to explore in the management of RES.
Secondary RES
The majority of RES described in the medical literature are
primary but secondary RES has been reported (25 cases).
Lance originally described the first series of 12 patients
with RES. Ten out of these patients had a secondarypathology thought to be responsible for the RE episodes
[2]. Subsequently other authors have reported cases of RES
secondary to an underlying pathology (Table 1) [7,9,10,16].
Secondary RES cases can be divided in two main groups:
upper cervical spine lesions and temporo-mandibular joint
dysfunction (TMJD). Eleven patients with RES secondary
to upper cervical spine abnormalities were found in the
literature. Different aetiologies have been implicated in-
cluding cervical spondylosis, infections of the meninges,
traction injury, narrowing of the neural foramen at the
side of the pain and congenital cervical abnormalities
(Table 1). Eleven patients with RES and co-existing TMJD
ipsilateral to the side of the pain have been described
[2,9,10,16]. One patient’s RES attacks settled with the use
of a dental plate seeming to point to a causal relationship
between TMJD and RES in this case [2].
Other secondary causes of RES include Chiari 1 malfor-
mation, thalamic syndrome and a neurovascular compres-
sion of the C3 root by the vertebral artery [2,9,21].
Investigations
Due to the association of secondary RES with upper cer-
vical spine pathology and TMJD, an MRI of the cervical
spine should be carried out and, when the clinical suspi-
cion for TMJD is high, an orthodontic assessment is
warranted. In addition, given the possible link between
RES and thalamic lesions [2,17], an MRI scan of the brain
should be included in the diagnostic work up of RES.
Given the description of a patient with chronic paroxys-
mal hemicrania (CPH), presenting as RES with unilateral
short-lasting, attacks of ear pain and redness, sometimes
involving the entire side of the face which responded to
indometacin [3], all patients with short-lasting strictly
unilateral side-locked attacks of ear pain and redness oc-
curring more than once a day should have a trial of
indometacin up to 225 mg a day [33], to exclude an
indometacin-sensitive headache disorder.
Treatment
Several of the drugs routinely used in primary headaches
and other pain syndromes have been tried in cases or
small series of RES patients in an open-label fashion. Most
of these drugs have been reported produce a marginal
benefit only. RES is, therefore, generally considered refrac-
tory to treatments. Medications with some reported effect
are summarised in Table 2.
Non-steroidal anti-inflammatory drugs
Ibuprofen taken daily was reported to be highly effective in
two patients with RES [10]. In one of these cases, the bene-
fits persisted even when the drug was discontinued due to
side effects, raising the possibility of a spontaneous im-
provement of the condition rather than a specific effect of
the medication. Conversely, ibuprofen 1200 mg for 7 days
Table 1 Secondary causes of red ear syndrome
Upper cervical spine • Hypertrophy of the ipsilateral C2-C3 facet joint
• Degeneration of superior facet of C4
• Cervical arachnoiditis with posterior column myelomalacia
• Traction injury of upper cervical roots
• Narrowing of C4 neural foramen
• Chari I malformation
• Chronic whiplash
• Congenital fusion of C1-C3 vertebrae with enlargement of the cervical spinal canal
• Neurovascular compression between vertebral artery and C3 root
Cranial and cervical neuralgias • Atypical glossopharyngeal neuralgia
• Atypical trigeminal neuralgia




Pleomorphic adenoma of carotid body
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given at the dose of 25 mg tds, completely suppressed the
pain in the patient with CPH-related RES [3] but when
tried in a dose up to 50 mg tds in other five patients with
RES, only one reported an improvement [10,16].
Tricyclic antidepressants
Three patients were said to respond to a trial of amitriptyl-
ine but no details of dosing were given [9]. Imipramine
125 mg daily was effective in one patient, reducing painTable 2 Effective treatments in red ear syndrome
Number of patients Type
Gabapentin 7 Primary an
Ice pack 4 Pri










Greater auricular nerve blockade 1 Priseverity by 50%, but no mention of any effect on ear red-
ness was made [2].Beta-blockers
The β-blocker propranolol was used at a dose of 40 mg
twice daily to successfully treatment one case of RES sec-
ondary to cervical spondylosis. However, in another case
of secondary RES associated with possible TMJD, pro-
pranolol was not found to be helpful [2].of RES Dosage Improvement
d secondary - Good
mary - Good
d secondary - Good
mary 50-75 mg/day 1 patient: pain free
1 patient: good
ndary 125 mg/day 50% reduction in pain
severity
ndary - -
mary 400 mg Pain free
ndary 80 mg Good
mary - -
mary - -
mary 600 mg Mild
ndary - -
mary 2% prilocaine 1 cc + 125 mg
methylprednisolone
Pain free
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Verapamil was reported to be effective in two RES patients.
In both these cases, the syndrome was associated with
other conditions such as chronic whiplash and TMJD. In
one patient, verapamil was administered in combination
with other drugs [16]. Flunarizine and nimodipine have
also been tried in two patients with migraine-related
RES. In both the cases, the treatments led to a reduction
in frequency and severity of both the RE and migraine
episodes [5].
Anticonvulsants
Gabapentin has been the most widely tried medication in
RES patients to date. In a series of 12 patients with RES,
seven of the eight on gabapentin reported a marked im-
provement in terms of frequency of attacks and ear colour
changes. One patient with possible cluster headache-re-
lated RES also responded to a combination of gabapentin
and verapamil although no information about dosages was
given [16]. One patient failing gabapentin did obtain a
slight reduction of pain using pregabalin 600 mg daily [12].
Serotonergic agonists and antagonists
Triptans have been tested in two patients with limited
benefit reported [16]. One patient with RES secondary to
cervical arachnoiditis, failed to respond to pizotifen, but
did show improvement with methysergide [2].
Topical lidocaine or steroidal application
Topical applications of anaesthetics and steroids are gen-
erally ineffective. Two patients failed topical application
of lidocaine [12,20] and two patients topical steroids
(clobetasol 0.05% cream being used in one such case)
[15,20]. However, cooling of the ear by application of an
ice-pack has been reported to provide significant relief in
five patients during an acute attack [2,5,15,19].
Local nerve blockade
Blocking the greater auricular nerve (GAN) with 1 cc
prilocaine 2% and 125 mg methylprednisolone in a patient
with RES led to a symptom free period of more than eight
weeks. In this case, RE episodes were brought on by light
touching of the ear and during these attacks the patient
reported GAN tenderness [11]. Lance reported a poor
outcome of C3 root blockades in two patients with RES.
The block was performed in one patient using bupivacaine
0.5%, with pain relief lasting only few hours, whereas a C2
and C3 root block in the second patient relieved the pain
for several hours [2].
Classification and diagnostic criteria
Given the relatively limited description of RES in terms of
aetiology, pathophysiology and treatment, it is currently
not included in the ICHD-II [34] and ICHD-IIIβ [22].Some authors have suggested that RES could be consid-
ered a form of TAC on the basis that both are a similar
phenotype characterized by short-lasting attacks of unilat-
eral pain, occurring once or more times a day associated
with cranial autonomic features [27]. Lance proposed that
since symptoms in RES are mostly centred over the ear-
lobe (which derives its sensory supply from C3), RES may
be a form of autonomic cephalalgia mediated by the
greater auricular nerve rather than the trigeminal nerve,
and that therefore, the term “auriculo-autonomic ce-
phalgia” rather than TAC should be used [26].
RES often appears to occur in associated with migraine
without aura. Indeed, 81% (n=60/74) of patients reported
in the literature with primary RES had a personal history
of migraine [5,6,9,13-16]. Given this striking association,
Raieli et al., suggested that RES be encompassed into the
wider clinical spectrum of migraine, with RES episodes
considered a migraine related phenomenon when occur-
ring during a migraine attack and an “acephalgic” mi-
graine phenomenon when occurring outside a migraine
attack [5]. Subsequently, the same authors studied a group
of 40 young migraineurs with RES and found that RES
was significantly associated with some of the migraine as-
sociated features, possibly explained by parasympathetic
nervous system activation. They concluded that RES could
be considered a specific sign of parasympathetic hyperac-
tivation via the trigemino-autonomic reflex, occurring
during migraine [13].
In view of its various possible aetiologies, other authors
argued that primary and secondary forms of RES be kept
separated. They proposed that primary RES be considered
a migraine-related phenomenon, whereas secondary forms
considered a neuralgiform radiculopathy involving the C3
root [7].
Although the pathophysiological mechanisms and con-
sequently the treatment of RES remains unclear, the clin-
ical description in 100 patients provides enough detail to
allow us to propose the first set of diagnostic criteria
(Table 3). We propose that RES be included in the 4th
Chapter of the IHS Classification, “Other Primary Head-
ache Disorders”, until further understanding regards its
pathophysiology and treatment emerges. Since secondary
forms of RES are rather frequent, physicians should care-
fully look for secondary causes of RES, namely a disease of
the upper cervical spine and TMJ dysfunction. Secondary
RES due to a disorder of the neck or TMJ should be clas-
sified within Chapter 11 of the ICHD-IIIβ (Headache or
facial pain attributed to disorder of the cranium, neck,
eyes, ears, nose, sinuses, teeth, mouth or other facial or
cervical structure).
Primary versus secondary RES
Although primary and secondary forms of RES share
common epidemiological and clinical characteristics,
Table 3 Proposed diagnostic criteria for primary red
ear syndrome
A. At least 20 attacks fulfilling criteria B-E
B. Episodes of external ear pain lasting up to 4 hours.
C. The ear pain has at least two of the following characteristics:
-Burning quality
-Unilateral location
-Mild to moderate severity
-Triggered by cutaneous or thermal stimulation of the ear.
D. The ear pain is accompanied by ipsilateral redness of the external ear.
E. Attacks occur with a frequency of ≥1 per day, although cases
with lower frequency may occur.
F. Not attributed to another disorder.
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ciated conditions have been described. For this reasons,
Donnet and Valade proposed to distinguish RES into two
separate types - a primary form that occurs in younger
people with a personal history of migraine, and a second-
ary form seen more frequently in older patients with
upper cervical spine pathology or TACs [6]. The analysis
of the published cases (Table 4) indicates that patients
with primary RES have a younger age of onset compared
to those with secondary RES and that whilst both forms
show a female preponderance this is more pronounced in
secondary RES. Clinically, a higher proportion of patients
with the secondary form of RES have daily and triggerable
attacks as compared to those with the primary form, a
difference that may be attributable to the underlyingTable 4 Characteristics of primary and secondary forms
of red ear syndrome (RES)




34 years (range: 5–74) 45 years (range: 9–76)
Gender Females: 37 (51%) Females: 17 (65%)
Males: 36 (49%) Males: 9 (35%)
RE episodes:
frequency***
≥ 1 attack/day: 17 (53%) ≥ 1 attack/day: 17 (77%)
< 1 attack/day: 15 (47%) < 1 attack/day: 5 (23%)
RE episodes:
duration**
<4 hours: 47 (94%) <4 hours: 13 (68%)
>4 hours: 3 (6%) >4 hours: 6 (32%)
Triggered
attacks
16/74 (22%) 18/26 (69%)
Personal history
of migraine
60/74 (81%) 6/26 (23%)
*The median age of onset in primary RES is based on 34 patients for whom
clear cut data were available.
**Clear cut duration of attacks was available for 50 patients with primary RES
and 19 patients with secondary RES.
***Data on attack frequency were available for 32 and 22 patients with
respectively primary and secondary RES.pathology. As suggested by Donnet and Valade, a higher
proportion of patients with primary RES had a personal
history of migraine.
In summary, the primary form of RES affects younger
males and females almost equally and is characterised by
short-lasting episodes occurring with a variable frequency.
Attacks are usually spontaneous and most patients have a
personal history of migraine. The secondary form of RES
occurs in older people, with a female preponderance,
usually without a personal history of migraine and is
characterised by short-lasting, daily attacks, often pro-
voked by specific triggers (Table 3). More clinical and
therapeutic data is needed to ascertain if primary and
secondary forms show different responses to medical
treatments, as suggested by some authors [10].
Conclusion
The features of RES have been reviewed in 100 patients.
RES is a rare but probably under-recognised condition
characterised by unilateral or bilateral episodes of burning
pain and erythema over the external ear. The episodes are
usually short-lasting and frequent. On the basis of the
clinical features described in literature, the first set of diag-
nostic criteria for RES has been proposed here.
Two different forms of RES can be distinguished: pri-
mary RES occurring in young individuals, often migrai-
neurs, and characterised mainly by spontaneous attacks,
sometimes temporally related to a migraine attack; and,
secondary RES occurring in older subjects with attacks
more likely provoked by cutaneous triggers, heat or
chewing. Symptomatic causes often responsible for sec-
ondary RES include upper cervical spine lesions and
TMJD. The diagnostic workup including an MRI scan of
the head and cervical spine, along with orthodontic assess-
ment is recommended in these patients.
RES appears generally refractory to medical treatments.
Open-label trials have suggested a beneficial effect with in
some cases with the use of gabapentin, amitriptyline, imipra-
mine, flunarizine, propranolol, verapamil and pregabalin.
Other treatments including NSAIDs, ice-pack use and block-
ade of the greater auricular nerve can also be considered.
Peripheral and central theories of the pathophysiology of
secondary and primary forms of RES have been proposed.
More recently a primary dysfunction of small sensory and
sympathetic fibres of the ear skin has been raised due to
the clinical overlap with EM. This hypothesis might justify
the use of medications that have not previously been tried
in this condition, such as sodium channel blockers, and
widen the therapeutic options for this syndrome.
Consent
Written informed consent was obtained from the pa-
tients for the publication of this report and any accom-
panying images.
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